Heba Alshaker

Norwich, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Beyond genes: EpiSwitch® and Orion platform-powered 3D genome architecture biomarkers reveal shared biology across ME/CFS, long COVID, PTSD, rheumatoid arthritis, and multiple sclerosis.

Beyond genes: EpiSwitch® and Orion platform-powered 3D genome architecture biomarkers reveal shared biology across ME/CFS, long COVID, PTSD, rheumatoid arthritis, and multiple sclerosis.

Journal: Journal of translational medicine

Published: June 16, 2026

Development and validation of blood-based diagnostic biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using EpiSwitch® 3-dimensional genomic regulatory immuno-genetic profiling.

Development and validation of blood-based diagnostic biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using EpiSwitch® 3-dimensional genomic regulatory immuno-genetic profiling.

Journal: Journal of translational medicine

Published: July 27, 2025

A New Blood-Based Epigenetic Diagnostic Biomarker Test (EpiSwitch®® NST) with High Sensitivity and Positive Predictive Value for Colorectal Cancer and Precancerous Polyps.

A New Blood-Based Epigenetic Diagnostic Biomarker Test (EpiSwitch®® NST) with High Sensitivity and Positive Predictive Value for Colorectal Cancer and Precancerous Polyps.

Journal: Cancers

Published: December 08, 2024

Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications.

Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications.

Journal: Cancers

Published: April 03, 2023

Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection.

Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection.

Journal: Cancers

Published: December 27, 2022

Monocytes acquire prostate cancer specific chromatin conformations upon indirect co-culture with prostate cancer cells.

Monocytes acquire prostate cancer specific chromatin conformations upon indirect co-culture with prostate cancer cells.

Journal: Frontiers in oncology

Published: July 10, 2022

Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups.

Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups.

Journal: Journal of translational medicine

Published: September 09, 2020

A case of severe dry eye disease with corneal melting as presenting complaint of acute myeloid leukaemia.

A case of severe dry eye disease with corneal melting as presenting complaint of acute myeloid leukaemia.

Journal: SAGE open medical case reports

Published: June 24, 2020

Sphingosine Kinase 1 in Breast Cancer-A New Molecular Marker and a Therapy Target.

Sphingosine Kinase 1 in Breast Cancer-A New Molecular Marker and a Therapy Target.

Journal: Frontiers in oncology

Published: November 25, 2019

Bradycardia and syncope as sole manifestations of a cranial lesion: a case report.

Bradycardia and syncope as sole manifestations of a cranial lesion: a case report.

Journal: Journal of medical case reports

Published: August 27, 2019

Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting.

Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting.

Journal: Frontiers in pharmacology

Published: December 13, 2018

Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors.

Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors.

Journal: Breast cancer research and treatment

Published: December 18, 2017

Showing 1-12 of 25

Last Updated: 09/26/2026